Share this
neoteryx: the blood microsampling innovator
by Neoteryx Microsampling on Oct 30, 2018 1:38:00 AM
Thanks to ongoing advances in technology, it is now feasible to get an enormous amount of data from very small amounts of biological fluid. And yet, until recently, there wasn't a good way to collect these small specimens, or microsamples.

Older microsampling methods involved collecting splotches of blood on special cards - a splotch is not a precise unit of measurement. This approach is referred to as dried blood spot, or DBS. The older DBS approach was to collect blood drops from a finger-prick onto a DBS card, which led to challenges such as the hematocrit bias, awkward automation, and more. Venipuncture blood draws were stressful for patients or study volunteers, and the cold chain biohazard shipping required for tubes of liquid blood was often cost-prohibitive. However, there was no alternative that covered everyone's needs.
That changed when a new wave of tenacious scientists began to take the issue of capillary blood sampling more seriously.
In the last few years, we've seen an innovation called volumetric absorptive microsampling, driven by the work of Neoteryx and its remarkable Mitra® devices, based on VAMS® technology.
Mitra devices are specially designed with absorptive, sponge-like VAMS® tips to collect precise, volumetrically accurate blood samples.
The samples can be allowed to dry on the tips, and they can be sealed into specimen bags and mailed direclty to labs via standard mail. The laboratory will process and analyze the specimens as dried blood samples.
Thanks to these innovations, professionals in fields ranging from pediatrics to clinical trials to monitoring antiepileptics and tacrolimus can collect samples in the perfect volumes their life-changing, world-changing work requires.
The early success of Neoteryx led Trajan Scientific and Medical to acquire this innovative microsampling device company. Neoteryx is now the microsampling brand of Trajan, offering an expanded range of products that include the Mitra device, the hemaPEN® microsampling device and, most recently, the Harpera™ microbiopsy tool.
Much of the spectacular achievements and progress associated with Neoteryx, Mitra and its VAMS technology come from close collaboration with trusted partners, including some of the biggest names in the worlds of clinical trials, clinical research, hospital labs, pediatrics, therapeutic drug monitoring, and far beyond.
The work of the Neoteryx microsampling team at Trajan benefits those working in scientific research, healthcare, wellness monitoring, pharmaceutical drug development and toxicology, among others. When these industries benefit - along with providers, patients, participants, and pediatric caregivers - Trajan benefits.
Trajan is now bringing volumetric absorptive microsampling into new realms, such as extraction automation, precision medicine, and other emerging areas of smarter science, healthcare and patient-centric medicine. We're proud to acknowledge what we've accomplished in collaboration with our partners, our all-star Advisory Council, and the microsampling community.
Learn more about microsampling and how it is applied in different industries:
Image Credits: Trajan, Neoteryx
Share this
- Microsampling (206)
- Research, Remote Research (119)
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (83)
- Mitra® Device (74)
- Therapeutic Drug Monitoring, TDM (51)
- Dried Blood Spot, DBS (38)
- Biomonitoring, Health, Wellness (31)
- Infectious Disease, Vaccines, COVID-19 (24)
- Blood Microsampling, Serology (22)
- Decentralized Clinical Trial (DCT) (22)
- Omics, Multi-Omics (20)
- Specimen Collection (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (17)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (12)
- Skin Microsampling, Microbiopsy (12)
- Pharmaceuticals, Drug Development (9)
- Harpera Device (5)
- Industry News, Microsampling News (5)
- Antibodies, MAbs (3)
- Company Press Release, Product Press Release (3)
- Environmental Toxins, Exposures (1)
- December 2024 (2)
- November 2024 (1)
- October 2024 (3)
- September 2024 (1)
- June 2024 (1)
- May 2024 (1)
- April 2024 (4)
- March 2024 (1)
- February 2024 (2)
- January 2024 (4)
- December 2023 (3)
- November 2023 (3)
- October 2023 (3)
- September 2023 (3)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (4)
- October 2019 (2)
- September 2019 (4)
- August 2019 (4)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (6)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
No Comments Yet
Let us know what you think